Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial

Alexej Ballhausen, Meinolf Karthaus, Stefan Fruehauf, Ullrich Graeven, Lothar Müller, Alexander Otto König, Ludwig Fischer von Weikersthal, Greta Sommerhäuser, Annabel Helga Sophie Alig, Eray Goekkurt, Johanna Wanda Meyer-Knees, Annika Kurreck, Arndt Stahler, Swantje Held, Stefan Kasper, Kathrin Heinrich, Volker Heinemann, Sebastian Stintzing, Tanja Trarbach, Dominik Paul Modest

Open source

DOI
10.1016/j.ejca.2023.112955
Published
2023-09
Container
European Journal of Cancer
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejca.2023.112955,
  title = {Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial},
  author = {Alexej Ballhausen and Meinolf Karthaus and Stefan Fruehauf and Ullrich Graeven and Lothar Müller and Alexander Otto König and Ludwig Fischer von Weikersthal and Greta Sommerhäuser and Annabel Helga Sophie Alig and Eray Goekkurt and Johanna Wanda Meyer-Knees and Annika Kurreck and Arndt Stahler and Swantje Held and Stefan Kasper and Kathrin Heinrich and Volker Heinemann and Sebastian Stintzing and Tanja Trarbach and Dominik Paul Modest},
  year = {2023},
  journal = {European Journal of Cancer},
  doi = {10.1016/j.ejca.2023.112955},
  url = {https://doi.org/10.1016/j.ejca.2023.112955}
}

RIS

TY  - JOUR
TI  - Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial
AU  - Alexej Ballhausen
AU  - Meinolf Karthaus
AU  - Stefan Fruehauf
AU  - Ullrich Graeven
AU  - Lothar Müller
AU  - Alexander Otto König
AU  - Ludwig Fischer von Weikersthal
AU  - Greta Sommerhäuser
AU  - Annabel Helga Sophie Alig
AU  - Eray Goekkurt
AU  - Johanna Wanda Meyer-Knees
AU  - Annika Kurreck
AU  - Arndt Stahler
AU  - Swantje Held
AU  - Stefan Kasper
AU  - Kathrin Heinrich
AU  - Volker Heinemann
AU  - Sebastian Stintzing
AU  - Tanja Trarbach
AU  - Dominik Paul Modest
PY  - 2023
JO  - European Journal of Cancer
DO  - 10.1016/j.ejca.2023.112955
UR  - https://doi.org/10.1016/j.ejca.2023.112955
ER  - 

APA

Ballhausen, A., Karthaus, M., Fruehauf, S., Graeven, U., Müller, L., König, A. O., Weikersthal, L. F. V., Sommerhäuser, G., Alig, A. H. S., Goekkurt, E., Meyer-Knees, J. W., Kurreck, A., Stahler, A., Held, S., Kasper, S., Heinrich, K., Heinemann, V., Stintzing, S., Trarbach, T., & Modest, D. P. (2023). Health-related quality of life in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab as maintenance therapy: a prespecified secondary analysis of the PanaMa (AIO KRK 0212) trial. European Journal of Cancer. https://doi.org/10.1016/j.ejca.2023.112955

Source records